Depression with or without co-morbid anxiety Mental and Behavioural Disorders Depression
Conditions
Interventions
Interventions as of 19/11/2018:
The trial uses a 2x2 factorial design, in which the conditions are derived from either the presence or non-presence of listening back to improvisations
12 bi-weekly sessions, 60 minutes each
delivered by qualified music therapists
Improvisational Integrative Music Therapy (IIMT) is a treatment model developed at our site (Department of Music, Art and Culture studies, University of Jyväskylä, Finland). IIMT consists of a) 5 to 1
Sponsors
University of Jyväskylä
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participant inclusion criteria as of 19/11/2018: 1. Participants must have depression as their primary diagnosis, according to the categories F32 or F33 of the ICD-10 2. Ager range: 18-55 years 3. Gender: Both 4. If diagnosed alongside the depression, anxiety will also be included, as both pathologies present a high level of co-morbidity 5. Musical skills or any form of musical background are not required; their presence, however, does not constitute a reason for exclusion Previous participant inclusion criteria: 1. Participants must have depression as their primary diagnosis, according to the categories F32 or F33 of the ICD-10 2. Ager range: 18-65 years 3. Gender: Both 4. If diagnosed alongside the depression, anxiety will also be included, as both pathologies present a high level of co-morbidity 5. Musical skills or any form of musical background are not required; their presence, however, does not constitute a reason for exclusion
Exclusion criteria
Exclusion criteria: 1. Psychosis 2. Combinations of psychiatric disorders in which depression cannot be defined as the primary disorder 3. Acute and severe substance misuse 5. Severe depression preventing the clients from participating in the measurements or engaging in verbal conversation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure as of 19/11/2018: Depression is measured using the MADRS (Montgomery-Åsberg Depression Rating Scale) at baseline, 6 weeks and 6 months. Previous primary outcome measure: Depression is measured using the MADRS (Montgomery-Åsberg Depression Rating Scale)at baseline, six weeks and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures as of 19/11/2018: 1. Anxiety is measured using Hospital Anxiety and Depression Scale at baseline, 6 weeks and 6 months. 2. Quality of Life is measured using RAND-36 at baseline, 6 weeks and 6 months. 3. Functioning is measured using Global Assessment of Functioning (GAF) at baseline, 6 weeks and 6 months. 4. Self-perceived depression levels are measured using a clinician questionnaire at each session of the intervention. Previous secondary outcome measures: 1. Anxiety is measured using Hospital Anxiety and Depression Scale at baseline, six weeks and 12 months. 2. Quality of Life is measured using RAND-36 at baseline, six weeks and 12 months. 3. Functioning is measured using Global Assessment of Functioning (GAF) at baseline, six weeks and 12 months. 4. Self-perceived depression levels are measured using a clinician questionnaire at each session of the intervention. | — |
Countries
Finland
Contacts
Public ContactMarkku Pöyhönen
Outcome results
None listed